Phthalate reduction as a mediator linking probiotic or yogurt consumption to reduced depressive Symptoms: Evidence from NHANES 2005-2018.

Abstract

Background: Depression may be influenced by environmental factors, including phthalate exposure as endocrine-disrupting chemicals (EDCs). Gut microbiota may modulate phthalate toxicity, and probiotics have been shown to alleviate depressive symptoms; however, their interrelationship remains unclear.

Methods: This cross-sectional study included 7999 participants from the 2005-2018 National Health and Nutrition Examination Survey (NHANES). Data on probiotic/yogurt consumption, urinary phthalate metabolites, depressive symptoms (measured by PHQ-9), and covariates were collected. Weighted generalized linear models (W-GLM) were employed to elucidate variable associations. Mediation analyses assessed whether phthalates mediated the association between probiotic/yogurt consumption and depressive symptoms. Similarly, subgroup analyses were conducted to elucidate sex-specific differences.

Results: The data revealed that probiotic/yogurt consumption was significantly associated with lower PHQ-9 scores. Furthermore, probiotic/yogurt consumption was inversely associated with urinary MBzP and MiBP levels, with MiBP mediating 7 % of its association with depressive symptoms. Multiple-group mediation analysis showed that the mediating effect was significant in females only, indicating possible sex-specific mechanisms.

Conclusions: Probiotic/yogurt consumption may be linked to reduced depressive symptoms via lowered phthalate exposure, particularly MiBP. Phthalates affect females more than males, suggesting sex-specific susceptibility to EDCs. Further studies are required to validate the underlying molecular mechanisms.